` Comparison: PRLD vs EPE - Alpha Spread

PRLD
vs
E
EPE

Over the past 12 months, PRLD has significantly outperformed EPE, delivering a return of +78% compared to the EPE's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
PRLD
EPE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

PRLD Intrinsic Value
HIDDEN
Show
EPE Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Prelude Therapeutics Inc
NASDAQ:PRLD
2.01 USD
E
Epizyme Inc
F:EPE
559 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
PRLD, EPE

PRLD
EPE
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Prelude Therapeutics Inc
Revenue
E
Epizyme Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
PRLD, EPE

PRLD
EPE
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Prelude Therapeutics Inc
NASDAQ:PRLD
E
Epizyme Inc
F:EPE
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

PRLD
0%
EPE
88.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

Operating Margin

PRLD
-516.7%
EPE
-435.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

Net Margin

PRLD
-461.5%
EPE
-460.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

FCF Margin

PRLD
-955.1%
EPE
-463.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

ROE

PRLD
-45.1%
EPE
-1 031.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

ROA

PRLD
-33.2%
EPE
-79.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

ROIC

PRLD
-144.8%
EPE
-213.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

ROCE

PRLD
-43.1%
EPE
-85.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Prelude Therapeutics Inc
E
Epizyme Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
PRLD, EPE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PRLD, EPE

Performance Gap Between PRLD and EPE
HIDDEN
Show

Performance By Year
PRLD, EPE

Loading
PRLD
EPE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare PRLD to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account